Litigation Details for Celgene Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)
✉ Email this page to a colleague
Celgene Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-07-10 |
| Court | District Court, D. Delaware | Date Terminated | 2016-08-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 7,608,280; 7,611,724 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Celgene Corporation v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Celgene Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-07-10 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,608,280 B2; 7,611,724 B2;. …2015 8 August 2016 1:15-cv-00589 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-08-09 | 45 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,608,280 B2; 7,611,724 B2. (…2015 8 August 2016 1:15-cv-00589 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
